Provided by Tiger Trade Technology Pte. Ltd.

Minerva Neurosciences

4.28
+0.07501.78%
Post-market: 4.280.00000.00%16:10 EDT
Volume:199.22K
Turnover:840.23K
Market Cap:199.40M
PE:-0.15
High:4.38
Open:4.19
Low:3.95
Close:4.21
52wk High:12.46
52wk Low:1.76
Shares:46.59M
Float Shares:30.87M
Volume Ratio:1.15
T/O Rate:0.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-29.0966
EPS(LYR):-34.6700
ROE:-675.09%
ROA:-27.47%
PB:-0.78
PE(LYR):-0.12

Loading ...

Minerva Neurosciences releases corporate presentation on roluperidone for negative symptoms of schizophrenia

Reuters
·
Jun 05

Minerva Neurosciences Updates Governance Following 2026 Shareholder Meeting

TIPRANKS
·
Jun 05

Minerva Neurosciences shareholders approve charter amendments at annual meeting

Reuters
·
Jun 05

Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs

THOMSON REUTERS
·
Jun 02

Minerva Neurosciences - Topline Data From 12-Week Phase a Expected in Second Half of 2027

THOMSON REUTERS
·
Jun 02

Minerva Neurosciences forms scientific advisory board for roluperidone program

Reuters
·
Jun 02

Minerva Neurosciences enters equity distribution deal for up to $75 million ATM offering

Reuters
·
May 28

Minerva Neurosciences - to Offer and Sell up to $75 Mln in Common Stock Through Leerink Partners - SEC Filing

THOMSON REUTERS
·
May 28

Minerva Neurosciences publishes corporate presentation on roluperidone for schizophrenia negative symptoms

Reuters
·
May 20

Minerva Neurosciences CEO joins Jefferies Global Healthcare Conference fireside chat

Reuters
·
May 19

Minerva Neurosciences Launches Key Phase 3 Test for Roluperidone in Schizophrenia

TIPRANKS
·
May 16

Minerva Neurosciences Q1 Adj. EPS $(0.17) Misses $(0.13) Estimate

Benzinga
·
May 05

Minerva Neurosciences Q1 net loss widens to $125.4 million

Reuters
·
May 05

Minerva Neurosciences Provides First Quarter 2026 Financial Results and Business Updates

GlobeNewswire
·
May 05

Minerva Neurosciences files Form 3 for Chief Business Officer and GC James Joseph O'Connor

Reuters
·
Apr 23

Minerva Neurosciences Initiated at Market Outperform by Citizens

Dow Jones
·
Apr 15

Minerva initiated with an Outperform at Citizens

TIPRANKS
·
Apr 15

Minerva Neurosciences announces upcoming annual shareholder meeting

Reuters
·
Apr 07

Minerva Neurosciences Appoints New Chief Business Officer, Counsel

TIPRANKS
·
Apr 03

Minerva appoints Jim O'Connor chief business officer as President Geoff Race exits

Reuters
·
Apr 03